CLU and type 2 diabetes mellitus: Interestingly, apoJ binds to subpopulations of LDL with increased negative charge LDL(−), as small dense LDL, which are increased in patients with T2DM and hypertriglyceridaemia, to prevent atherogenic modifications of LDL [177].